Podcast Summary: Tony Mantor – Why Not Me?
Episode Title: Dr Laitman: A Father’s Journey to Transform Schizophrenia Recovery
Release Date: March 4, 2026
Host: Tony Mantor
Guest: Dr. Robert Laitman
Episode Overview
In this compelling episode, Tony Mantor sits down with Dr. Robert Laitman, an internist and geriatrician who has devoted the past 20 years to improving treatment for people with schizophrenia and serious mental illness—driven by his son Daniel's diagnosis. Dr. Laitman shares a deeply personal journey that evolved into pioneering advocacy and clinical practice, emphasizing early intervention, effective medication, family involvement, and systemic change. This thoughtful conversation offers hope, practical advice, and a call for a more compassionate, science-based approach to psychosis and schizophrenia.
Key Discussion Points & Insights
1. Dr. Laitman’s Background & Personal Motivation
[05:25–06:05]
- Dr. Laitman specialized in internal medicine, nephrology, and geriatrics.
- Shifted focus to serious mental illness after his teenage son’s schizophrenia diagnosis.
- Frustration with the medical system’s lack of optimism and effective care inspired him to intervene personally.
Quote:
“We were told... mourn the loss of your son and your expectations. And I just didn’t find that to be an acceptable solution.” — Dr. Laitman [05:55]
2. Early Treatment Challenges & Advocating for Clozapine
[06:15–08:42]
- Initial resistance, even from within his own family, about treating his son as both a physician and parent.
- Multiple failed trials with antipsychotics. Whole year before Daniel could access clozapine, the only medication with proven efficacy for treatment-resistant schizophrenia.
- Described logistical hurdles (insurance, blood work, pharmacy) and why ultimately assuming direct care was necessary.
Memorable Moment:
Describes running his own in-office lab and the painstaking process to secure clozapine weekly for his son — “I just eventually took over. And it was much easier after that.” [07:41]
3. Managing Clozapine Side Effects: Practical & Personalized Approach
[08:48–11:36]
- Side effects are common but generally predictable and manageable:
- Excessive salivation → Treated with ipratropium spray, head elevation.
- Weight gain/appetite → Use of metformin, dietary changes, and encouraging exercise.
- Raised heart rate → Low-dose beta blockers.
- Holistic approach improved Daniel’s health and engagement (became pescatarian, exercises regularly).
Quote:
“It’s not the kids being a pig. The kid is almost driven to eat. So what do you do? You give them metformin. It’s not that hard.” — Dr. Laitman [10:38]
4. Evolution of Treatment: Cognitive Enhancement & Socialization
[11:52–13:48]
- Emphasizes social and cognitive deficits (negative symptoms) as central to psychosis, not just delusions/hallucinations.
- Engagement in cognitive behavioral therapy (CBT), exercise, and social activities is vital for recovery.
- Contradicts traditional view of never challenging delusions: psychosis-informed CBT can gradually reshape beliefs.
Quote:
“You can start to edge onto the delusions and start to challenge them. As you’re doing that, they’re more in touch with reality and their abilities improve.” [13:48]
- New in practice: Using Botox injections for severe salivation—borrowed from neurology and Parkinson’s treatments [14:21].
5. Navigating Anosognosia & Patient Engagement
[15:06–16:51]
- Daniel’s story: Early onset (age 15) is usually associated with poor prognosis, yet with comprehensive care, he is thriving.
- Discussed anosognosia (lack of insight): Daniel uniquely retained insight, helping adherence; most struggle and require legal measures (guardianship, court orders).
- Reflective listening (Javier Amador’s approach) and family partnerships are central, but sometimes mandated treatment is necessary.
Quote:
“Anosognosia... it’s also more complicated than that... He underestimates some of the things he can do and grossly overestimates others.” — Dr. Laitman [15:52]
6. Early Intervention Approach: The EASE Model
[19:24–21:20]
- EASE:
- Early: Treat quickly, especially as psychosis can be neurodegenerative.
- A (Assertive): Proactive management and wraparound services (medication, diet, exercise, CBT, socialization).
- Slow: Gradual medication titration, and realistic expectations about the long journey.
- Engagement: Patient and family involvement is key.
Quote:
“Psychosis is like a slow-moving stroke, and you lose about 1% of your brain per year.” [19:53]
7. Advocating Immediate Use of Clozapine
[21:25–23:21]
- Traditional practice is to reserve clozapine after two failed antipsychotics; Dr. Laitman argues for earlier use based on outcomes and reduced hospitalization.
- References UK studies and his own data showing remarkable acceptance (94% at one year) and recovery with prompt clozapine initiation.
Quote:
“I would use clozapine right at the inception of illness if I could.” [22:07]
8. Systemic Barriers: Workforce, Cost, Insurance
[23:35–27:38]
- Largest obstacles: reluctance from psychiatric community and economic challenges.
- Treatment is intensive, time-consuming, and undervalued; insurance rarely covers the full approach.
- Initiated Doramine, a clinic model using nurse practitioners for more scalable and affordable care.
- Demonstrated dramatic decrease in hospitalizations: from 93% admitted pre-treatment to only 15% post-treatment, across over 200 patients.
Quote:
“In treating serious mental illness... I’m actually making about a third of the amount that I was making back then [as a nephrologist]... Insurance will not pay for that.” [24:11]
9. Family Engagement & Overcoming Loneliness
[27:45–30:15]
- Normalizing social relationships, reducing isolation, and integrating families into care.
- Practical, compassionate stance on HIPAA: prioritizing patient safety and family engagement when appropriate.
Quote:
“Often the families are left out of the care of serious mental illness, and that’s just a sin.” [29:37]
10. Closing Thoughts: Hope & Advocacy
[30:24–33:07]
- Daniel’s recovery: now a working stand-up comic, role model for others with SMI.
- Dr. Laitman advocates for demanding the best—early, aggressive treatment, and not settling for minimal care.
- Outlines dramatic reductions in mortality and suicide rates with clozapine, backed by large-scale Finnish study and decades of clinical data.
- Announces the upcoming 5th edition of his book for both public and professionals: “Meaningful Recovery from Schizophrenia and Serious Mental Illness with Clozapine."
Quote:
“My message is: don’t settle. Demand the best treatment. That’s all I’m saying.” [32:55]
Notable Quotes & Moments (with Timestamps)
- “We were told... mourn the loss of your son and your expectations. And I just didn’t find that to be an acceptable solution.” — Dr. Laitman [05:55]
- “I just eventually took over. And it was much easier after that.” — Dr. Laitman [07:41]
- “It’s not the kids being a pig. The kid is almost driven to eat. So what do you do? You give them metformin. It’s not that hard.” — Dr. Laitman [10:38]
- “Psychosis is like a slow-moving stroke, and you lose about 1% of your brain per year.” — Dr. Laitman [19:53]
- “Anosognosia... it’s also more complicated than that... He underestimates some of the things he can do and grossly overestimates others.” — Dr. Laitman [15:52]
- “I would use clozapine right at the inception of illness if I could.” — Dr. Laitman [22:07]
- “My message is: don’t settle. Demand the best treatment. That’s all I’m saying.” — Dr. Laitman [32:55]
Segment Timestamps
- [05:19] – Start of Interview/Dr. Laitman’s motivation and background
- [06:05] – Navigating early treatment challenges, struggle for clozapine access
- [08:48] – Managing medication side effects practically
- [11:52] – Evolution in treatment: therapies beyond medication
- [13:20] – CBT, cognitive enhancement, and novel approaches (Botox etc.)
- [15:06] – Addressing anosognosia and treatment adherence
- [19:24] – EASE model and brain health
- [21:25] – The case for early clozapine use
- [23:35] – Systemic barriers: workforce, economics, Doramine clinic launch
- [27:45] – Family engagement, loneliness, and patient support
- [30:24] – Closing thoughts, hope, and advocacy
- [32:55] – “Don’t settle” message and resource/book announcement
Final Thoughts
This episode is a candid, deeply informed look at what it takes to move beyond stigma and statistics to real recovery in schizophrenia and serious mental illness. Dr. Laitman combines the rigor of medical science with the empathy of lived family experience—delivering actionable hope. Anyone touched by psychosis—patients, caregivers, clinicians—will find essential insights, practical advice, and encouragement to demand better for all.